Medicenna Therapeutics Corp. (MDNAF) at a glance

Medicenna Therapeutics Corp. (MDNAF) is a micro-cap Healthcare company. It trades at $0.29, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 38/100 overall. Its strongest dimension is Value (50/100) and its weakest is Momentum (15/100). It carries above-market volatility, so expect larger swings.

Price

$0.29

Market cap

$25.8M

P/E ratio

n/a

Dividend yield

None

Beta

1.85

52-week range

$0.25 to $1.43